Fiduciary Trust Sponsors JDRF Greater Bay Area Chapter’s Annual Meeting, Supports Organization’s Research to Fight and Tr...
September 05 2019 - 12:00PM
Fiduciary Trust Company International, a global wealth manager and
wholly-owned subsidiary of Franklin Templeton, is proud to partner
with JDRF, a leading funder of type 1 diabetes (T1D) research, to
sponsor the annual meeting of the global organization’s Greater Bay
Area Chapter.
The chapter meeting—taking place today at the City Club in San
Francisco—will include a presentation about foundation activities
and research advancements during the year, and feature a panel
discussion about the soon-to-be-launched JDRF Northern California
Center of Excellence. The Center will combine the scientific
expertise and resources of Stanford University and the University
of California-San Francisco (UCSF) within a collaborative structure
in order to spearhead research leading to stem cell-based cures and
treatments for T1D.
Matthias Hebrok, PhD of UCSF; Seung Kim, MD, PhD of Stanford
University; and Aaron J. Kowalski, PhD, President and CEO of
JDRF—who will work together to lead the Center when it opens—will
talk about the Center and its research focus during the panel
discussion.
“We are honored to support our local JDRF chapter at a time when
the research it funds is closer than ever to making a cure for type
1 diabetes a reality,” said Suzanne E. Kline, Fiduciary Trust
Company International’s regional managing director for Northern
California. “Making a positive impact on the communities where we
and our clients live and work is a key pillar of Fiduciary Trust’s
corporate culture, and the JDRF Northern California Center of
Excellence will change many people’s lives for the better in our
area and around the world.”
Fiduciary Trust’s parent company, Franklin Resources, Inc.
(NYSE: BEN), operating as Franklin Templeton, partners with JDRF to
provide year-round support for the organization, including
sponsorship of key T1D awareness and fundraising events. Jenny
Johnson, Franklin Templeton president and chief operating officer,
and her family have also dedicated themselves to helping the JDRF
Greater Bay Area Chapter raise funds for research leading to a cure
for T1D. Former Chairman and CEO Charles B. Johnson and his wife,
Ann, were recognized for their efforts at the JDRF Hope Gala in
2009.
For more information about JDRF’s Greater Bay Area Chapter and
its activities, please visit https://www.jdrf.org/bayarea/.
“We are excited to partner with Fiduciary Trust and Franklin
Templeton, and thankful for their sponsorship of our chapter’s 2019
annual meeting and research update,” said Nicole Friedland,
executive director of the JDRF Greater Bay Area Chapter. “Their
generous support enables us to share the vital work we’re doing for
our community and raise awareness about the exciting advancements
we’re making in type 1 diabetes research. Fiduciary Trust’s
sponsorship also allows more funds to be directed to the most
promising scientific studies of type 1 diabetes, which will help
accelerate breakthroughs toward a cure.”
About JDRFJDRF is the leading global
organization funding type 1 diabetes (T1D) research. Our mission is
to improve lives today and tomorrow by accelerating life-changing
breakthroughs to cure, prevent, and treat T1D and its
complications. To accomplish this, JDRF has invested more than $2.2
billion in research funding since our inception. We are an
organization built on a grassroots model of people connecting in
their local communities, collaborating regionally for efficiency
and broader fundraising impact, and uniting on a national stage to
pool resources, passion, and energy. We collaborate with academic
institutions, policymakers, and corporate and industry partners to
develop and deliver a pipeline of innovative therapies to people
living with T1D. Our staff and volunteers throughout the United
States and our six international affiliates are dedicated to
advocacy, community engagement, and our vision of a world without
T1D. For more information, please visit jdrf.org or follow us on
Twitter: @JDRF.
About Fiduciary TrustFiduciary Trust Company
International, a global wealth management firm, has served
individuals, families, endowments and foundations since 1931. With
over $75 billion in assets under administration and management as
of June 30, 2019, the firm specializes in strategic wealth
planning, investment management and trust and estate services, as
well as tax and custody services. The firm and its subsidiaries
maintain offices in New York, NY, Coral Gables, FL, Boca Raton, FL,
St. Petersburg, FL, Los Angeles, CA, San Mateo, CA, San Francisco,
CA, Washington, DC, Wilmington, DE, and Arlington, VA. For more
information, please visit fiduciarytrust.com, and for the latest
updates, follow Fiduciary Trust on LinkedIn and Twitter:
@FiduciaryTrust.
About Franklin TempletonFranklin Resources,
Inc. [NYSE:BEN] is a global investment management organization
operating as Franklin Templeton. Franklin Templeton’s goal is
to deliver better outcomes by providing global and domestic
investment management to retail, institutional and sovereign wealth
clients in over 170 countries. Through specialized teams, the
Company has expertise across all asset classes, including equity,
fixed income, alternatives and custom multi-asset solutions. The
Company’s more than 600 investment professionals are supported by
its integrated, worldwide team of risk management professionals and
global trading desk network. With employees in over 30
countries, the California-based company has more than 70 years of
investment experience and over US$709 billion in assets under
management as of July 31, 2019. For more information, please
visit franklintempleton.com.
Copyright © 2019. Fiduciary Trust Company International. All
rights reserved.
Contacts:
- Rebecca Radosevich:
212-632-3207rebecca.radosevich@franklintempleton.com
- Laura Simpson: 973-850-7319lsimpson@jconnelly.com
Franklin Resources (NYSE:BEN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Franklin Resources (NYSE:BEN)
Historical Stock Chart
From Apr 2023 to Apr 2024